Paris, France

Matthieu Montes

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Matthieu Montes: Innovator in Therapeutic Agents

Introduction

Matthieu Montes is a notable inventor based in Paris, France. He has made significant contributions to the field of therapeutic agents, holding a total of 3 patents. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Montes' latest patents include groundbreaking inventions such as polypeptides capable of inhibiting the binding between leptin and Neuropilin-1. This invention relates to agents that can inhibit the binding between Leptin and Neuropilin-1 (NRP1), with potential applications in the therapeutic field. Another significant patent is the anti-IL-6 vaccine composition, which comprises a pharmaceutical composition containing at least one polypeptide made up of a sequence of contiguous amino acids derived from the interleukin-6 sequence.

Career Highlights

Throughout his career, Matthieu Montes has worked with esteemed organizations, including the Institut National de la Santé et de la Recherche Médicale. His innovative work has positioned him as a key figure in the development of therapeutic solutions.

Collaborations

Montes has collaborated with notable professionals in his field, including Jean-François Zagury and Hadley Mouhsine. These collaborations have further enhanced his research and development efforts.

Conclusion

Matthieu Montes is a distinguished inventor whose work in therapeutic agents has the potential to make a significant impact on healthcare. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…